2 632

Cited 0 times in

Nine-Month Angiographic and Intravascular Ultrasound Outcomes After Resolute Zotarolimus-Eluting Stent Implantation for the Treatment of In-Stent Restenosis

DC Field Value Language
dc.contributor.author권혁문-
dc.contributor.author김병극-
dc.contributor.author김중선-
dc.contributor.author이승률-
dc.contributor.author장양수-
dc.contributor.author홍명기-
dc.contributor.author이승율-
dc.date.accessioned2014-12-18T09:52:27Z-
dc.date.available2014-12-18T09:52:27Z-
dc.date.issued2013-
dc.identifier.issn0896-4327-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/88990-
dc.description.abstractOBJECTIVES: We aimed to evaluate the mid-term outcomes of resolute zotarolimus-eluting stent (R-ZES) implantation for in-stent restenosis (ISR). BACKGROUND: There has been a paucity of data regarding the effects of new-generation drug-eluting stent to treat ISR. METHODS: From 2009 to 2010, a total of 98 patients with 98 ISR lesions were prospectively enrolled after R-ZES implantation for the treatment of ISR. Among 98 patients, 73 patients underwent follow-up angiography at 9 months. Serial intravascular ultrasound (IVUS) at both postprocedure and 9 months was evaluated in 55 patients. The overlapped segment of R-ZES was defined as the portion of R-ZES superimposed on previous stent. RESULTS: Late loss and binary restenosis rate were 0.3 ± 0.5 mm and 5.5% at 9 months. On IVUS, the percentage of neointimal volume and maximum percentage of neointimal area were 3.9 ± 6.3% and 17.3 ± 15.5%, respectively. There was no significant change of vessel volume index between postprocedure and 9 months (16.9 ± 4.7 mm³ /mm vs. 17.1 ± 4.6 mm³ /mm, P = 0.251). Late-acquired incomplete stent apposition was observed in 5 (5/55, 9.1%) cases. Compared with nonoverlapped segments of R-ZES, the overlapped did not show larger neointimal volume index (0.3 ± 0.5 mm³ /mm vs. 0.2 ± 0.3 mm³ /mm, P = 0.187) on 9-month IVUS. During follow-up (median, 353 days), repeat target-lesion revascularization was performed in four cases, but there were no death or stent thrombosis. CONCLUSIONS: This study suggested that R-ZES implantation for the treatment of ISR was effective up to 9 months and showed favorable vascular responses on serial IVUS assessment.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfJOURNAL OF INTERVENTIONAL CARDIOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHCoronary Angiography*-
dc.subject.MESHCoronary Restenosis/diagnosis*-
dc.subject.MESHCoronary Restenosis/therapy*-
dc.subject.MESHDrug-Eluting Stents*-
dc.subject.MESHFemale-
dc.subject.MESHFollow-Up Studies-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHSirolimus/administration & dosage-
dc.subject.MESHSirolimus/analogs & derivatives*-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUltrasonography, Interventional*-
dc.titleNine-Month Angiographic and Intravascular Ultrasound Outcomes After Resolute Zotarolimus-Eluting Stent Implantation for the Treatment of In-Stent Restenosis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorSEUNG-YUL LEE-
dc.contributor.googleauthorBYEONG-KEUK KIM-
dc.contributor.googleauthorJUNG-SUN KIM-
dc.contributor.googleauthorMYEONG-KI HONG-
dc.contributor.googleauthorDEOK-KYU CHO-
dc.contributor.googleauthorJUNGHAN YOON-
dc.contributor.googleauthorDONG WOON JEON-
dc.contributor.googleauthorNAM-HO LEE-
dc.contributor.googleauthorHYUCK MOON KWON-
dc.contributor.googleauthorYANGSOO JANG-
dc.identifier.doi10.1111/joic.12073-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00260-
dc.contributor.localIdA00493-
dc.contributor.localIdA00961-
dc.contributor.localIdA03448-
dc.contributor.localIdA04391-
dc.contributor.localIdA02922-
dc.relation.journalcodeJ01465-
dc.identifier.eissn1540-8183-
dc.identifier.pmid24308658-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1111/joic.12073/abstract-
dc.subject.keywordCoronary Angiography*-
dc.subject.keywordCoronary Restenosis/diagnosis*-
dc.subject.keywordCoronary Restenosis/therapy*-
dc.subject.keywordDrug-Eluting Stents*-
dc.subject.keywordFemale-
dc.subject.keywordFollow-Up Studies-
dc.subject.keywordHumans-
dc.subject.keywordMale-
dc.subject.keywordMiddle Aged-
dc.subject.keywordSirolimus/administration & dosage-
dc.subject.keywordSirolimus/analogs & derivatives*-
dc.subject.keywordTime Factors-
dc.subject.keywordTreatment Outcome-
dc.subject.keywordUltrasonography, Interventional*-
dc.contributor.alternativeNameKwon, Hyuck Moon-
dc.contributor.alternativeNameKim, Byeong Keuk-
dc.contributor.alternativeNameKim, Jung Sun-
dc.contributor.alternativeNameLee, Seung Yul-
dc.contributor.alternativeNameJang, Yang Soo-
dc.contributor.alternativeNameHong, Myeong Ki-
dc.contributor.affiliatedAuthorKwon, Hyuck Moon-
dc.contributor.affiliatedAuthorKim, Byeong Keuk-
dc.contributor.affiliatedAuthorKim, Jung Sun-
dc.contributor.affiliatedAuthorJang, Yang Soo-
dc.contributor.affiliatedAuthorHong, Myeong Ki-
dc.contributor.affiliatedAuthorLee, Seung Yul-
dc.rights.accessRightsnot free-
dc.citation.volume26-
dc.citation.number6-
dc.citation.startPage543-
dc.citation.endPage549-
dc.identifier.bibliographicCitationJOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol.26(6) : 543-549, 2013-
dc.identifier.rimsid33727-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.